International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-3 doi: 10.5281/zenodo.13219078
Original Research Article
Remarks on Metabolic Health Conference 2024: In light of personal experience and scientific literature
Published
June 6, 2024
Abstract

This article aims to provide a remark on the second Metabolic Health Conference (MHC2), which was recently held from April 26 to 28, 2024. The authors are researchers who participated in MHC-2 as speakers and wanted to provide a remark which should reach diverse professionals and members of the public. The authors formulate this remark by using their personal experience at the conference and critically reflecting on the relevant scientific literature. This article finds the following.

While India  needs novel approaches to  address  its increasing  metabolic health issues, and  while  adopting such  approaches is  challenging, the Metabolic  Health Conferences (MHCs) serve as a promising hope. Moreover, the first Metabolic Health Conference (MHC-1) and MHC-2 fill the gap of roughly 115 years, as within this span,  it is hard to find a conference exclusively dedicated to discussing the low-carbohydrate approach in light of diabetes and metabolic syndrome in India.

Additionally, because of MHC-1 and MHC-2, for the first time in the history of the Indian low-carbohydrate movement, numerous stakeholders—researchers, doctors, health professionals, and organisations—across the globe united to discuss the lowcarbohydrate approach in light of the Indian population's diverse metabolic health issues. These conferences are an essential resource for contemporary and future researchers and practitioners. Therefore, MHC-1 and MHC-2 are pivotal in reshaping Indian public health

Recommended Articles
Loading Image...
Volume-5, Issue-3
Citations
2189 Views
167 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved